Kathleen A. Rickard, the Chief Medical Officer of $VRNA, sold 79,264 shares of the company on 03-12-2025 for an estimated $661,941. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.9% of their shares of this class of stock. Following this trade, they now own 2,608,976 shares of this class of $VRNA stock.
$VRNA Insider Trading Activity
$VRNA insiders have traded $VRNA stock on the open market 37 times in the past 6 months. Of those trades, 3 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $VRNA stock by insiders over the last 6 months:
- DAVID ZACCARDELLI (President and CEO) has made 0 purchases and 16 sales selling 1,800,000 shares for an estimated $8,511,810.
- MARK W HAHN (Chief Financial Officer) has made 0 purchases and 16 sales selling 1,800,000 shares for an estimated $8,511,194.
- KATHLEEN A. RICKARD (Chief Medical Officer) has made 0 purchases and 2 sales selling 319,264 shares for an estimated $1,838,301.
- DAVID R EBSWORTH has made 2 purchases buying 59,360 shares for an estimated $277,680 and 0 sales.
- CHRISTINA ACKERMANN purchased 41,880 shares for an estimated $198,385
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNA Hedge Fund Activity
We have seen 103 institutional investors add shares of $VRNA stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. removed 3,242,823 shares (-64.7%) from their portfolio in Q4 2024, for an estimated $150,596,700
- ORBIMED ADVISORS LLC removed 2,861,801 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $82,334,014
- CARLYLE GROUP INC. removed 2,457,500 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $70,702,275
- DEEP TRACK CAPITAL, LP removed 2,330,025 shares (-73.3%) from their portfolio in Q4 2024, for an estimated $108,206,361
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC added 1,902,026 shares (+inf%) to their portfolio in Q4 2024, for an estimated $88,330,087
- RTW INVESTMENTS, LP added 1,821,019 shares (+inf%) to their portfolio in Q4 2024, for an estimated $84,568,122
- VIVO CAPITAL, LLC removed 1,265,783 shares (-35.7%) from their portfolio in Q4 2024, for an estimated $58,782,962
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
